ID
34430
Description
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification; ODM derived from: https://clinicaltrials.gov/show/NCT02468661
Link
https://clinicaltrials.gov/show/NCT02468661
Keywords
Versions (3)
- 17/1/19 17/1/19 -
- 20/4/20 20/4/20 -
- 25/4/20 25/4/20 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
17 de enero de 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Small Cell Lung Cancer NCT02468661
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.6
Data type
boolean
Description
ID.7
Data type
boolean
Description
ID.8
Data type
boolean
Description
ID.9
Data type
boolean
Description
ID.10
Data type
boolean
Similar models
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility